A detailed history of Seven Eight Capital, LP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 4,638 shares of LNTH stock, worth $419,831. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,638
Previous 18,971 75.55%
Holding current value
$419,831
Previous $1.52 Million 66.58%
% of portfolio
0.05%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$77.7 - $123.62 $1.11 Million - $1.77 Million
-14,333 Reduced 75.55%
4,638 $509,000
Q2 2024

Aug 12, 2024

BUY
$58.87 - $83.05 $1.12 Million - $1.58 Million
18,971 New
18,971 $1.52 Million
Q4 2022

Feb 13, 2023

BUY
$48.76 - $77.67 $3.43 Million - $5.46 Million
70,323 New
70,323 $3.58 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.